Diagnostic and clinicopathological significance of Ki67 mRNA expression in cervical cancer tissue

Dawn Chung, Sunyoung Park, Geehyuk Kim, Hye Young Wang, Kwang Hwa Park, Sang Wun Kim, Sunghoon Kim, YoungTae Kim, Hyeyoung Lee, Eun Ji Nam

Research output: Contribution to journalArticle

Abstract

Ki67 is a key biomarker associated with cancer cell proliferation and poor prognosis. We previously evaluated the diagnostic potential of quantitatively measured Ki67 mRNA levels in formalin-fixed paraffin-embedded (FFPE) cervical cancer tissue samples. In the present study, we continued this avenue of research using quantitative reverse transcriptase PCR (RT-qPCR) to measure Ki67 mRNA levels in FFPE cervical tissues and performed an assessment with each clinical prognostic factor of patients. We obtained 190 FFPE cervical tissue samples that comprised of 80 squamous cell carcinoma (SCC), 10 adenocarcinoma (ADC), 30 HSIL, 30 LSIL, and 40 normal cervical tissue samples. And using this assay, we also evaluated the predictive value of Ki67 in cases with a lowgrade squamous intraepithelial lesion (LSIL) and those with a high-grade squamous intraepithelial lesion (HSIL). As a result, Ki67 mRNA levels were increased in SCC and ADC cervical cancer tissues (n = 90) compared to those in normal cervical tissues (n = 40) (P < 0.001). The diagnostic validity of the Ki67 mRNA assay was evaluated and demonstrated a sensitivity of 93.3% (95% confidence interval (CI) = 86.1 to 97.5) and a specificity of 97.5% (95% CI = 86.8 to 99.9). Ki67 mRNA positivity was 93.3% for cervical cancer, 40.0% for HSIL, 13.3% for LSIL, and 2.5% for normal tissue samples. Furthermore, we found that high levels of Ki67 mRNA expression in cervical cancer were associated with lymph node status (P = 0.01). In conclusion, Ki67 mRNA assay can provide an additional accurate approach for molecular diagnosing cervical cancer, and also predict prognosis of cervical cancer depending on LSIL and/or HSIL status.

Original languageEnglish
Pages (from-to)6956-6964
Number of pages9
JournalInternational Journal of Clinical and Experimental Pathology
Volume10
Issue number6
Publication statusPublished - 2017 Jan 1

Fingerprint

Uterine Cervical Neoplasms
Messenger RNA
Paraffin
Formaldehyde
Squamous Cell Carcinoma
Adenocarcinoma
Confidence Intervals
Squamous Intraepithelial Lesions of the Cervix
Reverse Transcriptase Polymerase Chain Reaction
Biomarkers
Lymph Nodes
Cell Proliferation
Research
Neoplasms

All Science Journal Classification (ASJC) codes

  • Pathology and Forensic Medicine
  • Histology

Cite this

Chung, D., Park, S., Kim, G., Wang, H. Y., Park, K. H., Kim, S. W., ... Nam, E. J. (2017). Diagnostic and clinicopathological significance of Ki67 mRNA expression in cervical cancer tissue. International Journal of Clinical and Experimental Pathology, 10(6), 6956-6964.
Chung, Dawn ; Park, Sunyoung ; Kim, Geehyuk ; Wang, Hye Young ; Park, Kwang Hwa ; Kim, Sang Wun ; Kim, Sunghoon ; Kim, YoungTae ; Lee, Hyeyoung ; Nam, Eun Ji. / Diagnostic and clinicopathological significance of Ki67 mRNA expression in cervical cancer tissue. In: International Journal of Clinical and Experimental Pathology. 2017 ; Vol. 10, No. 6. pp. 6956-6964.
@article{412596e33d114aca86cb93f314f68735,
title = "Diagnostic and clinicopathological significance of Ki67 mRNA expression in cervical cancer tissue",
abstract = "Ki67 is a key biomarker associated with cancer cell proliferation and poor prognosis. We previously evaluated the diagnostic potential of quantitatively measured Ki67 mRNA levels in formalin-fixed paraffin-embedded (FFPE) cervical cancer tissue samples. In the present study, we continued this avenue of research using quantitative reverse transcriptase PCR (RT-qPCR) to measure Ki67 mRNA levels in FFPE cervical tissues and performed an assessment with each clinical prognostic factor of patients. We obtained 190 FFPE cervical tissue samples that comprised of 80 squamous cell carcinoma (SCC), 10 adenocarcinoma (ADC), 30 HSIL, 30 LSIL, and 40 normal cervical tissue samples. And using this assay, we also evaluated the predictive value of Ki67 in cases with a lowgrade squamous intraepithelial lesion (LSIL) and those with a high-grade squamous intraepithelial lesion (HSIL). As a result, Ki67 mRNA levels were increased in SCC and ADC cervical cancer tissues (n = 90) compared to those in normal cervical tissues (n = 40) (P < 0.001). The diagnostic validity of the Ki67 mRNA assay was evaluated and demonstrated a sensitivity of 93.3{\%} (95{\%} confidence interval (CI) = 86.1 to 97.5) and a specificity of 97.5{\%} (95{\%} CI = 86.8 to 99.9). Ki67 mRNA positivity was 93.3{\%} for cervical cancer, 40.0{\%} for HSIL, 13.3{\%} for LSIL, and 2.5{\%} for normal tissue samples. Furthermore, we found that high levels of Ki67 mRNA expression in cervical cancer were associated with lymph node status (P = 0.01). In conclusion, Ki67 mRNA assay can provide an additional accurate approach for molecular diagnosing cervical cancer, and also predict prognosis of cervical cancer depending on LSIL and/or HSIL status.",
author = "Dawn Chung and Sunyoung Park and Geehyuk Kim and Wang, {Hye Young} and Park, {Kwang Hwa} and Kim, {Sang Wun} and Sunghoon Kim and YoungTae Kim and Hyeyoung Lee and Nam, {Eun Ji}",
year = "2017",
month = "1",
day = "1",
language = "English",
volume = "10",
pages = "6956--6964",
journal = "International Journal of Clinical and Experimental Pathology",
issn = "1936-2625",
publisher = "e-Century Publishing Corporation",
number = "6",

}

Diagnostic and clinicopathological significance of Ki67 mRNA expression in cervical cancer tissue. / Chung, Dawn; Park, Sunyoung; Kim, Geehyuk; Wang, Hye Young; Park, Kwang Hwa; Kim, Sang Wun; Kim, Sunghoon; Kim, YoungTae; Lee, Hyeyoung; Nam, Eun Ji.

In: International Journal of Clinical and Experimental Pathology, Vol. 10, No. 6, 01.01.2017, p. 6956-6964.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Diagnostic and clinicopathological significance of Ki67 mRNA expression in cervical cancer tissue

AU - Chung, Dawn

AU - Park, Sunyoung

AU - Kim, Geehyuk

AU - Wang, Hye Young

AU - Park, Kwang Hwa

AU - Kim, Sang Wun

AU - Kim, Sunghoon

AU - Kim, YoungTae

AU - Lee, Hyeyoung

AU - Nam, Eun Ji

PY - 2017/1/1

Y1 - 2017/1/1

N2 - Ki67 is a key biomarker associated with cancer cell proliferation and poor prognosis. We previously evaluated the diagnostic potential of quantitatively measured Ki67 mRNA levels in formalin-fixed paraffin-embedded (FFPE) cervical cancer tissue samples. In the present study, we continued this avenue of research using quantitative reverse transcriptase PCR (RT-qPCR) to measure Ki67 mRNA levels in FFPE cervical tissues and performed an assessment with each clinical prognostic factor of patients. We obtained 190 FFPE cervical tissue samples that comprised of 80 squamous cell carcinoma (SCC), 10 adenocarcinoma (ADC), 30 HSIL, 30 LSIL, and 40 normal cervical tissue samples. And using this assay, we also evaluated the predictive value of Ki67 in cases with a lowgrade squamous intraepithelial lesion (LSIL) and those with a high-grade squamous intraepithelial lesion (HSIL). As a result, Ki67 mRNA levels were increased in SCC and ADC cervical cancer tissues (n = 90) compared to those in normal cervical tissues (n = 40) (P < 0.001). The diagnostic validity of the Ki67 mRNA assay was evaluated and demonstrated a sensitivity of 93.3% (95% confidence interval (CI) = 86.1 to 97.5) and a specificity of 97.5% (95% CI = 86.8 to 99.9). Ki67 mRNA positivity was 93.3% for cervical cancer, 40.0% for HSIL, 13.3% for LSIL, and 2.5% for normal tissue samples. Furthermore, we found that high levels of Ki67 mRNA expression in cervical cancer were associated with lymph node status (P = 0.01). In conclusion, Ki67 mRNA assay can provide an additional accurate approach for molecular diagnosing cervical cancer, and also predict prognosis of cervical cancer depending on LSIL and/or HSIL status.

AB - Ki67 is a key biomarker associated with cancer cell proliferation and poor prognosis. We previously evaluated the diagnostic potential of quantitatively measured Ki67 mRNA levels in formalin-fixed paraffin-embedded (FFPE) cervical cancer tissue samples. In the present study, we continued this avenue of research using quantitative reverse transcriptase PCR (RT-qPCR) to measure Ki67 mRNA levels in FFPE cervical tissues and performed an assessment with each clinical prognostic factor of patients. We obtained 190 FFPE cervical tissue samples that comprised of 80 squamous cell carcinoma (SCC), 10 adenocarcinoma (ADC), 30 HSIL, 30 LSIL, and 40 normal cervical tissue samples. And using this assay, we also evaluated the predictive value of Ki67 in cases with a lowgrade squamous intraepithelial lesion (LSIL) and those with a high-grade squamous intraepithelial lesion (HSIL). As a result, Ki67 mRNA levels were increased in SCC and ADC cervical cancer tissues (n = 90) compared to those in normal cervical tissues (n = 40) (P < 0.001). The diagnostic validity of the Ki67 mRNA assay was evaluated and demonstrated a sensitivity of 93.3% (95% confidence interval (CI) = 86.1 to 97.5) and a specificity of 97.5% (95% CI = 86.8 to 99.9). Ki67 mRNA positivity was 93.3% for cervical cancer, 40.0% for HSIL, 13.3% for LSIL, and 2.5% for normal tissue samples. Furthermore, we found that high levels of Ki67 mRNA expression in cervical cancer were associated with lymph node status (P = 0.01). In conclusion, Ki67 mRNA assay can provide an additional accurate approach for molecular diagnosing cervical cancer, and also predict prognosis of cervical cancer depending on LSIL and/or HSIL status.

UR - http://www.scopus.com/inward/record.url?scp=85021184663&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85021184663&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:85021184663

VL - 10

SP - 6956

EP - 6964

JO - International Journal of Clinical and Experimental Pathology

JF - International Journal of Clinical and Experimental Pathology

SN - 1936-2625

IS - 6

ER -